CTSO - CIK 0001175151
The table below shows Cytosorbents Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.25M | $3.28M | $14.13M | $22.14M | $52.14M | $71.42M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $7.55M | $7.32M | $6.06M | $5.66M | $4.52M | $5.16M |
| Inventory | $5.28M | $2.73M | $3.68M | $3.46M | $4.77M | $2.67M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $20.63M |
| $21.60M |
| $25.70M |
| $33.76M |
| $64.30M |
| $82.45M |
| Property, plant & equipment | $7.82M | $9.00M | $10.06M | $10.74M | $5.15M | $2.12M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $44.18M | $47.37M | $53.26M | $63.23M | $89.52M | $89.95M |
| Accounts payable | $2.87M | $3.34M | $3.80M | $1.66M | $2.81M | $1.84M |
| Total current liabilities | $9.71M | $9.82M | $14.55M | $9.71M | $13.69M | $10.15M |
| Long-term debt | $16.67M | $14.00M | $2.54M | $5.00M | - | $0.00 |
| Total liabilities | $38.28M | $36.26M | $29.99M | $27.86M | $26.94M | $10.73M |
| Retained earnings | -$312.21M | -$304.01M | -$282.51M | -$254.00M | -$221.19M | -$196.63M |
| Total equity | $5.90M | $11.11M | $23.28M | $35.37M | $62.58M | $79.22M |